FdaApplication
NDA 021369
Identifiers
- fda_app_no: NDA021369
Properties
| Property | Value |
|---|---|
| applicant_name | LANNETT CO INC |
| application_type | NDA |
| approval_date | 2004-06-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CODEPREX | CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX | EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML | SUSPENSION, EXTENDED RELEASE;ORAL |
1 product